US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 0.3696
  • -0.0142-3.70%
Trading Apr 29 10:17 ET
46.06MMarket Cap-0.66P/E (TTM)

About Mersana Therapeutics Company

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRSN
Company NameMersana Therapeutics
Listing DateJun 28, 2017
Issue Price15.00
Founded2001
CEODr. Martin H. Huber, M.D.
MarketNASDAQ
Employees102
Fiscal Year Ends12-31
Address840 Memorial Drive
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-498-0020
Websitehttp://www.mersana.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Martin H. Huber, M.D.
  • Director, President and Chief Executive Officer
  • 2.60M
  • Alejandra Carvajal
  • Senior Vice President and Chief Legal Officer
  • 1.61M
  • Mohan Bala
  • Senior Vice President and Chief Development Officer
  • 1.58M
  • Dr. Tushar Misra, PhD
  • Senior Vice President and Chief Manufacturing Officer
  • --
  • Dr. Timothy B. Lowinger, PhD
  • Senior Vice President, Chief Science and Technology Officer
  • 1.69M
  • Brian DeSchuytner
  • Senior Vice President, Chief Operating Officer and Chief Financial Officer
  • 1.74M
  • Ashish Mandelia
  • Vice President, Controller and Principal Accounting Officer
  • --
  • David M. Mott
  • Chairman of the Board
  • 329.93K
  • Anna Protopapas
  • Director
  • 4.45M
  • Allene M. Diaz
  • Independent Director
  • 294.93K
  • Lawrence M. Alleva
  • Independent Director
  • 308.93K
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 305.43K
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • 293.43K
  • Dr. Andrew A. F. Hack, M.D.,PhD
  • Independent Director
  • 297.43K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Workday
WDAY
242.160
Collegium Pharmaceutical
COLL
27.110
Cars.com
CARS
11.920
4
Constellation Brands
STZ
185.760
5
eBay
EBAY
66.650
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀